Gene Therapy for Sanfilippo Syndrome Wins FDA Approval After Family’s Fundraising Efforts
A gene therapy for Sanfilippo syndrome Type A won FDA approval in September at a list price of nearly $4 million, after a fundraising campaign by one South Carolina family helped carry the treatment from a mouse lab to the market.